Samar Alanazi

770 total citations · 1 hit paper
13 papers, 575 citations indexed

About

Samar Alanazi is a scholar working on Oncology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Samar Alanazi has authored 13 papers receiving a total of 575 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 6 papers in Molecular Biology and 6 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Samar Alanazi's work include HER2/EGFR in Cancer Research (6 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and Melanoma and MAPK Pathways (3 papers). Samar Alanazi is often cited by papers focused on HER2/EGFR in Cancer Research (6 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and Melanoma and MAPK Pathways (3 papers). Samar Alanazi collaborates with scholars based in United States, Saudi Arabia and United Kingdom. Samar Alanazi's co-authors include Rosalin Mishra, Joan T. Garrett, Hima Patel, Long Yuan, Tarjani Thaker, Natalia Jura, Pankaj B. Desai, Edward J. Merino, Haizhou Zhu and Sarah J. Storr and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Cancer Research.

In The Last Decade

Samar Alanazi

12 papers receiving 568 citations

Hit Papers

PI3K Inhibitors in Cancer: Clinical Implications and Adve... 2021 2026 2022 2024 2021 50 100 150
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. PI3K Inhibitors in Cancer: Clinical Implications and Adverse Effects
    2021 194 citations Rosalin Mishra, Hima Patel et al. International Journal of Molecular Sciences profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Samar Alanazi United States 8 347 271 102 101 66 13 575
Rosalin Mishra United States 11 421 1.2× 345 1.3× 139 1.4× 131 1.3× 81 1.2× 20 724
Grit S. Herter-Sprie United States 10 350 1.0× 307 1.1× 103 1.0× 46 0.5× 137 2.1× 14 680
Neha Luthar United States 6 236 0.7× 292 1.1× 139 1.4× 75 0.7× 64 1.0× 6 525
B. Markman Australia 8 469 1.4× 293 1.1× 152 1.5× 64 0.6× 69 1.0× 20 688
James W. Purcell United States 13 271 0.8× 295 1.1× 83 0.8× 56 0.6× 80 1.2× 18 591
Steve Guerrero United States 5 431 1.2× 221 0.8× 86 0.8× 64 0.6× 128 1.9× 6 621
Elisabeth Llonch Switzerland 2 509 1.5× 214 0.8× 128 1.3× 48 0.5× 93 1.4× 2 651
Andrew E. Aplin United States 15 604 1.7× 363 1.3× 75 0.7× 39 0.4× 64 1.0× 22 722
Bernhard Heinrich Germany 14 160 0.5× 439 1.6× 187 1.8× 129 1.3× 66 1.0× 36 630
Vivien N. Jacobs United Kingdom 11 290 0.8× 194 0.7× 67 0.7× 39 0.4× 53 0.8× 18 504

Countries citing papers authored by Samar Alanazi

Since Specialization
Citations

This map shows the geographic impact of Samar Alanazi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Samar Alanazi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Samar Alanazi more than expected).

Fields of papers citing papers by Samar Alanazi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Samar Alanazi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Samar Alanazi. The network helps show where Samar Alanazi may publish in the future.

Co-authorship network of co-authors of Samar Alanazi

This figure shows the co-authorship network connecting the top 25 collaborators of Samar Alanazi. A scholar is included among the top collaborators of Samar Alanazi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Samar Alanazi. Samar Alanazi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Alanazi, Samar, et al.. (2024). Early visual and clinical outcomes of transepithelial photorefractive keratectomy versus transepithelial keratectomy with smart pulse technology for myopia. SHILAP Revista de lepidopterología. 17(3). 337–341. 1 indexed citations
2.
Alanazi, Samar, et al.. (2023). HER2 inhibition increases non-muscle myosin IIA to promote tumorigenesis in HER2+ breast cancers. PLoS ONE. 18(5). e0285251–e0285251. 4 indexed citations
3.
Alanazi, Samar, et al.. (2022). Effects of caffeine and peppermint consumption on GERD patients in Saudi Arabia. Medical Science. 26(130). 1–9. 1 indexed citations
4.
Patel, Hima, et al.. (2022). HER3 Alterations in Cancer and Potential Clinical Implications. Cancers. 14(24). 6174–6174. 13 indexed citations
5.
Mishra, Rosalin, et al.. (2022). Abstract 5412: Role of her3 mutations on breast cancer oncogenesis. Cancer Research. 82(12_Supplement). 5412–5412.
6.
Patel, Hima, et al.. (2021). IGF1R/IR Mediates Resistance to BRAF and MEK Inhibitors in BRAF-Mutant Melanoma. Cancers. 13(22). 5863–5863. 19 indexed citations
7.
Mishra, Rosalin, et al.. (2021). PI3K Inhibitors in Cancer: Clinical Implications and Adverse Effects. International Journal of Molecular Sciences. 22(7). 3464–3464. 194 indexed citations breakdown →
8.
9.
Mishra, Rosalin, Long Yuan, Hima Patel, et al.. (2021). Phosphoinositide 3-Kinase (PI3K) Reactive Oxygen Species (ROS)-Activated Prodrug in Combination with Anthracycline Impairs PI3K Signaling, Increases DNA Damage Response and Reduces Breast Cancer Cell Growth. International Journal of Molecular Sciences. 22(4). 2088–2088. 18 indexed citations
10.
Patel, Hima, et al.. (2020). Current Advances in the Treatment of BRAF-Mutant Melanoma. Cancers. 12(2). 482–482. 132 indexed citations
11.
12.
Mishra, Rosalin, Hima Patel, Samar Alanazi, Long Yuan, & Joan T. Garrett. (2018). HER3 signaling and targeted therapy in cancer. Oncology Reviews. 12(1). 355–355. 140 indexed citations
13.
Mishra, Rosalin, Samar Alanazi, Long Yuan, et al.. (2018). Activating HER3 mutations in breast cancer. Oncotarget. 9(45). 27773–27788. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rosalin Mishra Breakdown of academic impact, for papers by Grit S. Herter-Sprie Breakdown of academic impact, for papers by Neha Luthar Breakdown of academic impact, for papers by B. Markman Breakdown of academic impact, for papers by James W. Purcell Breakdown of academic impact, for papers by Steve Guerrero Breakdown of academic impact, for papers by Elisabeth Llonch Breakdown of academic impact, for papers by Andrew E. Aplin Breakdown of academic impact, for papers by Bernhard Heinrich Breakdown of academic impact, for papers by Vivien N. Jacobs
Rankless by CCL
2026